Skip to Main Content

Paper Details

Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohorts.
Alzheimers Dement
152
2018
APOE 4, Alzheimer, Alzheimer's Disease, Alzheimer's disease, Apolipoprotein 4, amyloid (A), apolipoprotein, apolipoprotein 4, apolipoprotein E, apolipoprotein E genotype, cognitive decline, dementia
Author NameAffiliation
Heidi I L JacobsMassachusetts General Hospital/Harvard Medical School, Maastricht University
Bernard HanseeuwMassachusetts General Hospital and Harvard Medical School, USA Center for Alzheimer Research and Treatment, Brigham and Women's Hospital, Cliniques Universitaires Saint-Luc, Institute of Neuroscience, Universite Catholique de Louvain
Paul Maruff
Michael C DonohueUniversity of Southern California
Keith A JohnsonMassachusetts General Hospital/Harvard Medical School
Reisa A SperlingMassachusetts General Hospital and Harvard Medical School, USA Center for Alzheimer Research and Treatment, Brigham and Women's Hospital
  • 1 - 6

Datasets

Release 1.2